Watanabe S, Sato H, Tawaraya K, Tsubota M, Endo M, Seki M, Yamada T, Nakagawa M
Department of Thoracic and Cardiovascular Surgery, Ishikawa Prefectural Central Hospital, Kanazawa, Japan.
Jpn J Thorac Cardiovasc Surg. 1998 Jun;46(6):549-55. doi: 10.1007/BF03250598.
We studied the significance of Systemic Inflammatory Response Syndrome (SIRS) state after surgical treatment of thoracic esophageal cancer. From January 1991 to December 1995, 35 patients received thoracic esophageal cancer surgery. Thirty three patients (94.3%) were in the SIRS state after surgery and mean duration of SIRS was 3.4 days. Duration of SIRS was statistically longer in patients with pulmonary complications. Patients with hyperbilirubinemia (> or = 3.0 mg/dl) after surgery had longer duration of SIRS. Induction therapy did not affect the duration of SIRS. Collectively, duration of SIRS is an indication of complications, especially of pulmonary complications, after surgical treatment of thoracic esophageal cancer, and blood bililubin score after surgery correlates to duration of SIRS. These suggest that we must pay special attention to patients with long duration of SIRS or hyperbilirubinemia after thoracic esophageal surgery.
我们研究了胸段食管癌手术治疗后全身炎症反应综合征（SIRS）状态的意义。1991年1月至1995年12月，35例患者接受了胸段食管癌手术。33例患者（94.3%）术后处于SIRS状态，SIRS的平均持续时间为3.4天。肺部并发症患者的SIRS持续时间在统计学上更长。术后出现高胆红素血症（≥3.0mg/dl）的患者SIRS持续时间更长。诱导治疗不影响SIRS的持续时间。总体而言，SIRS的持续时间是胸段食管癌手术治疗后并发症尤其是肺部并发症的一个指标，术后血胆红素评分与SIRS的持续时间相关。这些表明，我们必须特别关注胸段食管癌手术后SIRS持续时间长或有高胆红素血症的患者。
